Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Beckman Coulter Laboratory Systems (suzhou) Co., Ltd. recalls DxC 500 AU Clinical Chemistry Analyzer

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Beckman Coulter has identified an issue which prevents the DxC 500 AU instrument from providing the correct onboard stability (Open Expiration) dates for assays that were loaded prior to a software upgrade (e.g. 1.3 to 1.4, 1.4 to 1.4.1, etc.). As a result, assays that have expired may still be used for sample processing, leading to inaccurate or erroneous patient test results. The issue only happens on assays loaded before instruments doing upgrades and does not impact new installation. It does not impact the assays loaded after upgrade.
Products
  • DxC 500 AU Clinical Chemistry Analyzer
Company
Beckman Coulter Laboratory Systems (suzhou) Co., Ltd.
Where it was sold

US: MA, CA, SC, LA, OK, GA, AL, TX, OR, ID, CO, MN, NY, MS, PA, WA, IL, MI, PR. OUS: Lebanon, Poland, Ghana, Spain, South Africa, Slovakia, Ghana, Croatia, Seychelles, Australia, Republic of Korea

States: Alabama, California, Colorado, Georgia, Idaho, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, New York, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, Texas, Washington

Units affected
56
About this recall
DxC 500 AU Clinical Chemistry Analyzer, REF: C63519, and C63520 with affected software.